SNORD13P3

Across TCGA pan-cancer cohorts, SNORD13P3 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated SNORD13P3 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher SNORD13P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD13P3 expression acts as an unfavorable survival marker, although some lineages such as PAAD and LAML show a favorable association.

LUSC, CESC, and OV are the cancer types where SNORD13P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.238	0.428	<.001	120	view →
CESC	DFS	Tertile	All	0.484	0.764	<.001	72	view →
OV	OS	Quartile	All	0.258	0.354	.009	68	view →
UCEC	DFS	Tertile	IV	0.301	0.736	.003	66	view →
SARC	DFS	Tertile	All	0.190	0.533	<.001	36	view →
ESCA	DFS	Tertile	III,IV	0.255	0.575	.002	31	view →
STAD	DFS	Tertile	IV	0.197	0.647	.003	27	view →
LIHC	DFS	Tertile	All	0.344	0.566	.014	27	view →
LGG	OS	Tertile	All	0.693	0.848	.018	24	view →
THCA	OS	Tertile	IV	0.484	0.924	<.001	24	view →
PAAD	OS	Tertile	II,III,IV	0.638	0.391	.015	21	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

SNORD13P3–LUSC (OS)

Open the LUSC breakdown →